New drug OP-3136 enters first human tests for tough cancers

NCT ID NCT06784193

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 25 times

Summary

This early-phase study tests a new drug called OP-3136 in people with advanced breast, lung, or prostate cancers that have stopped responding to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors or slow cancer growth. About 180 adults will take part, receiving OP-3136 alone or combined with another cancer drug.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cancer Research South Australia

    RECRUITING

    Adelaide, South Australia, 5000, Australia

  • Dana-Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Florida Cancer Specialists

    RECRUITING

    Sarasota, Florida, 34232, United States

  • SCRI Oncology Partners

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • START - Midwest

    RECRUITING

    Grand Rapids, Michigan, 49546, United States

  • START - Mountain Region

    RECRUITING

    West Valley City, Utah, 84119, United States

  • START - San Antonio

    RECRUITING

    San Antonio, Texas, 78229, United States

  • University Medical Center - New Orleans

    RECRUITING

    New Orleans, Louisiana, 70112, United States

Conditions

Explore the condition pages connected to this study.